TCTAP A-001 Thirty-day Clinical Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients Presenting with Acute Coronary Syndromes Versus Stable Coronary Artery Disease: Results from the Italian RAI Registry
2017
Bioresorbable vascular scaffold (BVS) technology represents a revolutionary concept in interventional cardiology. It appears an attractive alternative to metallic drug-eluting stents and its use is rapidly extending even to complex lesions. However concerns have been raised to an increased risk
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI